Effects of various tetracycline derivatives on in vitro and in vivo β-oxidation of fatty acids, egress of triglycerides from the liver, accumulation of hepatic triglycerides, and mortality in mice-Reference-Cited by-同舟云学术

Effects of various tetracycline derivatives on in vitro and in vivo β-oxidation of fatty acids, egress of triglycerides from the liver, accumulation of hepatic triglycerides, and mortality in mice

Published:1991-02 Issue:4 Volume:41 Page:638-641
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Labbe Gilles,Fromenty Bernard,Freneaux Eric,Morzelle Veronique,Letteron Philippe,Berson Alain,Pessayre Dominique

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference18 articles.

1. Hepatotoxicity, The Adverse Effects of Drugs and Other Chemicals on the Liver;Zimmerman,1978

2. Inhibition of the mitochondrial oxidation of fatty acids by tetracycline in mice and in man: possible role in microvesicular steatosis induced by this antibiotic;Fréneaux;Hepatology,1988

3. The effect of tetracycline on the hepatic secretion of triglyceride;Breen;Biochim Biophys Acta,1972

4. Fatty liver induced by tetracycline in the rat. Dose-response relationships and effect of sex;Breen;Gastroenterology,1975

5. Investigation into the mechanism of tetracycline-induced steatosis: Study in isolated hepatocytes;Deboyser;Toxicol Appl Pharmacol,1989

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug-induced impairment of mitochondrial fatty acid oxidation and steatosis: assessment of causal relationship with 45 pharmaceuticals;Toxicological Sciences;2024-04-27

2. Alteration of mitochondrial DNA homeostasis in drug-induced liver injury;Food and Chemical Toxicology;2020-01

3. Early detection of metabolic changes in drug-induced steatosis using metabolomics approaches;RSC Advances;2020

4. Hepatoprotective effects of rosmarinic acid: Insight into its mechanisms of action;Biomedicine & Pharmacotherapy;2019-04

5. Drug-induced liver injury in obesity and nonalcoholic fatty liver disease;Advances in Pharmacology;2019